At current prices Novo Nordisk is a Strong Buy. It's good positioning in the promising weight loss segment, solid foundation ...

Viking Therapeutics (NASDAQ:VKTX), often touted as an attractive obesity play, shed more than a third of its value this week ...

Robert F. Kennedy Jr.’s leadership at HHS sparks controversy as his vaccine agenda reshapes policy, regulation, and public health.

Incorporating top stocks from a variety of sectors can be an effective way to balance out an investment portfolio.